{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:50:30Z","timestamp":1793303430050,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,13]],"date-time":"2007-10-13T00:00:00Z","timestamp":1192233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00417-007-0684-4","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T07:52:21Z","timestamp":1192175541000},"page":"281-284","source":"Crossref","is-referenced-by-count":138,"title":["Bevacizumab (Avastin) eye drops inhibit corneal neovascularization"],"prefix":"10.1007","volume":"246","author":[{"given":"Felix","family":"Bock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,13]]},"reference":[{"key":"684_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2006.03.058","volume":"142","author":"SJ Bakri","year":"2006","unstructured":"Bakri SJ, Cameron JD, McCannel CA, Pulido JS, Marler RJ (2006) Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol 142:162\u2013164","journal-title":"Am J Ophthalmol"},{"key":"684_CR2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","volume":"48","author":"F Bock","year":"2007","unstructured":"Bock F, Onderka J, Dietrich T, Dietrich T, Bachmann B, Kruse FE, Cursiefen C (2007) Bevacizumab is a potent inhibitor of inflammatory angiogenesis and lymphangiogenesis in the cornea. Invest Ophthalmol Vis Sci 48:2545\u20132552","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"684_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00347-007-1512-2","volume":"104","author":"F Bock","year":"2007","unstructured":"Bock F, K\u00f6nig Y, Dietrich T, Zimmermann P, Baier M, Cursiefen C (2007) Inhibition of angiogenesis in the anterior chamber of the eye. Ophthalmologe 104:336\u2013344","journal-title":"Ophthalmologe"},{"key":"684_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242\u2013249","journal-title":"Curr Opin Ophthalmol"},{"key":"684_CR5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00003226-200007000-00025","volume":"19","author":"C Cursiefen","year":"2000","unstructured":"Cursiefen C, Rummelt C, K\u00fcchle M (2000) Immunohistochemical localization of VEGF, TGF\u03b1 and TGF\u03b21 in human corneas with neovascularization. Cornea 19:526\u2013533","journal-title":"Cornea"},{"key":"684_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U (2003) Pericyte recruitment in human corneal angiogenesis. Br J Ophthalmol 87:101\u2013106","journal-title":"Br J Ophthalmol"},{"key":"684_CR7","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Maruyama K, Liu Y, Chen L, Jackson D, Wiegand S, Dana MR, Streilein JW (2004) Inhibition of hem- and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666\u20132673","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"684_CR8","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Streilein JW, Dana MR (2006) Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 103:11405\u201311410","journal-title":"Proc Natl Acad Sci USA"},{"key":"684_CR9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","volume":"91","author":"R Manzano","year":"2007","unstructured":"Manzano R, Peyman G, Khan P, Carvounis PE, Kivilcim M, Ren M, Lake JC, Chevez-Barrios P (2007) Inhibition of experimental corneal neovascularization by bevacizumab (Avastin). Br J Ophthalmol 91:804\u2013807","journal-title":"Br J Ophthalmol"},{"key":"684_CR10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","volume":"245","author":"M Erdurmus","year":"2007","unstructured":"Erdurmus M, Totan Y (2007) Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 245:1577\u20131579","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"684_CR11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.ico.0000157400.81408.2b","volume":"24","author":"A Kuhlmann","year":"2005","unstructured":"Kuhlmann A, Amann K, Schl\u00f6tzer-Schrehardt U, Kruse FE, Cursiefen C (2005) Endothelin-1 and Eta\/Etb-receptor protein and mRNA expression in normal and vascularized human corneas. Cornea 24:837\u2013844","journal-title":"Cornea"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0684-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-007-0684-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-007-0684-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:35Z","timestamp":1559072435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-007-0684-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,13]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s00417-007-0684-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,13]]}}}